Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus ...

Study urges industry to be more transparent and fairer in selecting speakers, and to recruit more women to steering ...

Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the tally of failed drugs in the innovative “Healey platform trial” to seven.

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

This article will explore what DLBCL is and how clinical trials can potentially lead to breakthroughs in treatment.

Discover how wearable devices like Apple Watches and Fitbits can detect signs of IBD flares weeks before symptoms appear, ...

Large drugmakers are acquiring smaller biotechs, making IBD candidates with improved clinical profiles. In 2024, Lilly acquired Morphic Therapeutics, which added its pipeline candidate MORF-057 ...

Image credit: Skorzewiak / Shutterstock AbbVie executives say the company’s immunology drugs Skyrizi and Rinvoq are expanding their reach in the inflammatory bowel disease (IBD ... from the EMPOWER-1 ...

(Inflammatory Bowel Diseases) Authors of a narrative review in Clinical ... patients with IBD. (Clinical Gastroenterology and Hepatology) In a placebo-controlled phase II trial, fecal microbiota ...

Previously approved for ulcerative colitis in October 2023, Omvoh (mirikizumab-mrkz) enters an increasingly crowded IBD drug market ... phase 3 VIVID-1 trial, which assessed the efficacy of ...